LongBio Pharma (Suzhou) Co., Ltd. (HKG:1779)
89.85
-5.20 (-5.47%)
Jul 9, 2026, 4:08 PM HKT
| Market Cap | 6.67B |
| Revenue (ttm) | n/a |
| Net Income | -195.39M |
| EPS | -3.45 |
| Shares Out | 74.19M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 128,600 |
| Open | 96.95 |
| Previous Close | 95.05 |
| Day's Range | 85.00 - 99.90 |
| 52-Week Range | 87.55 - 165.90 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |